Overview

A Study of Belzutifan (MK-6482) and Metformin in Healthy Adult Participants (MK-6482-039)

Status:
ACTIVE_NOT_RECRUITING
Trial end date:
2025-09-26
Target enrollment:
Participant gender:
Summary
The goal of this study is to learn how belzutifan (MK-6482) affects the levels of metformin in a healthy person's body over time. Researchers will study levels of metformin in the blood and urine in healthy volunteers after taking metformin alone (Period 1) and metformin with belzutifan (Period 2).
Phase:
PHASE1
Details
Lead Sponsor:
Merck Sharp & Dohme LLC
Treatments:
belzutifan
Metformin